Form 4: MicroVision Director Jada Smith Converts RSUs to Stock
Insider Transaction Report
MicroVision Director Jada Smith acquired 22,007 shares of common stock through the vesting of restricted stock units on December 1, 2025, increasing her direct beneficial ownership to 104,351 shares.
Summary
- Jada Smith, a Director of MicroVision, Inc. (MVIS), acquired 22,007 shares of common stock on December 1, 2025.
- The acquisition resulted from the vesting of restricted stock units (RSUs) on a unit-for-share basis, without payment.
- Following this transaction, Jada Smith directly beneficially owns 104,351 shares of MicroVision common stock.
- Concurrently, 22,007 derivative securities (Restricted Stock Units) were disposed of due to their conversion into common stock.
- A previous Form 4 filed on June 6, 2025, incorrectly reported 87,462 RSUs granted on June 5, 2025; the correct amount was 88,028 RSUs, and the current vesting is based on this corrected amount.
- The RSUs granted on June 6, 2025, are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on continued directorship.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as a director is increasing their direct ownership in the company through a scheduled vesting event, which aligns their interests with shareholders. It is not a discretionary purchase, so the positive signal is moderate.
Positives
- The transaction represents a director increasing their direct beneficial ownership in the company, which can signal continued alignment with shareholder interests.
- The vesting of RSUs is a standard compensation mechanism, indicating the director is receiving earned equity.
Future Outlook
The remaining unvested RSUs granted on June 6, 2025, are scheduled to vest in subsequent equal quarterly installments, contingent on Jada Smith's continued service as a director until the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders.
Industry Context
This filing is a routine insider transaction report (Form 4) detailing the vesting of restricted stock units for a director. Such transactions are common across publicly traded companies as part of executive and director compensation packages and do not inherently reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders may view the increase in director's direct ownership positively, as it suggests continued alignment of interests between management and investors.
Next Steps
- Future quarterly vesting of the remaining restricted stock units granted on June 6, 2025, will occur, provided the reporting person continues to serve as a director.
Key Dates
| Date | Description |
|---|---|
| 06/05/2025 | Original grant date for RSUs (incorrectly reported in a previous filing). |
| 06/06/2025 | Date RSUs were granted and incorrectly reported in a previous Form 4 filing. |
| 12/01/2025 | Transaction date for the vesting and acquisition of common stock. |
| 12/02/2025 | Date the Form 4 was signed. |
| 2026 | Year of the Issuer's Annual Meeting of Stockholders, which is a potential full vesting date for RSUs. |
Recommendation
holdThis Form 4 details a routine, scheduled vesting of restricted stock units, which is a compensation event rather than a discretionary investment decision by the director. While it increases the director's direct ownership, it does not provide new fundamental information about the company's performance or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as it reflects a neutral impact on the stock's investment thesis based solely on this filing.
Keywords
MVIS, MicroVision, Jada Smith, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Common Stock, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.